Mirae Asset Global Investments Co., Ltd. Zai Lab LTD Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Zai Lab LTD stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 77,857 shares of ZLAB stock, worth $2.54 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
77,857
Previous 2,132,201
96.35%
Holding current value
$2.54 Million
Previous $77.1 Million
96.47%
% of portfolio
0.01%
Previous 0.21%
Shares
22 transactions
Others Institutions Holding ZLAB
# of Institutions
170Shares Held
38.6MCall Options Held
150KPut Options Held
201K-
Capital World Investors Los Angeles, CA6.04MShares$197 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$180 Million2.97% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$131 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X02.2MShares$71.6 Million0.04% of portfolio
-
Bamco Inc New York, NY1.59MShares$51.7 Million0.16% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.19B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...